We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System
Product News

Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System

Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System
Product News

Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Beckman Coulter Diagnostics Showcases the New DxN VERIS Molecular Diagnostics System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Beckman Coulter Diagnostics is showcasing its DxN VERIS Molecular Diagnostics System at the European Society for Clinical Virology (ESCV) meeting in Edinburgh, Scotland, 9-12 September 2015 on booth G5 where delegates can learn more about this new instrument that is set to revolutionize laboratory workflow.

Recent evaluations undertaken in the UK and Spain have shown that DxN VERIS is simple to use (routine operator training taking approximately 20 minutes from start to full system operation), dramatically reduces hands-on time (as only one instrument is required that incorporates extraction, amplification and detection), provides true single sample random access allowing multiple assays and samples to be run at the same time, and enables laboratories to go from sample to auto-verified result in just 70 minutes.

Assays are supplied in a unique, single cartridge system so, unlike traditional batch-plate systems, there are no empty wells, reducing wastage and consumable costs.

With the DxN VERIS Molecular Diagnostics System, all necessary consumables and reagents are on-board, so there is no lengthy set-up and tests can be up and running in less than 10 minutes.

The system is fully CE-marked, with assays for Human Immunodeficiency Virus (HIV-1), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and Human Cytomegalovirus (CMV). Further menu expansion will follow with many other assays currently in development.

Advertisement